Successful Use of Ketamine for the Treatment of Psychotic Depression in a Teenager

Cullen KR , Amatya P , Roback MG , Albott CS , Westlund Schreiner M , Ren Y , Eberly LE , Carstedt P , Samikoglu A , Gunlicks-Stoessel M , Reigstad K , Horek N , Tye S , Lim KO , Klimes-Dougan B : Intravenous ketamine for adolescents with treatment-resistant depression: An open-label study. J Child Adolesc Psychopharmacol, 28:437–444, 2018.

Dwyer JB , Beyer C , Wilkinson S , Ostroff R , Qayyum Z , Bloch M : Ketamine as a treatment for adolescent depression: A case report. J Am Acad Child Adolesc Psychiatry, 56:352–353, 2017.

Fitzgerald AS , O'Malley PG : Staying on track when prescribing off-label. Am Fam Phys, 89:4–5, 2014.

Sanacora G , Frye MA , McDonald W , Mathew SJ , Turner MS , Schatzberg AF , Summergrad P , Nemeroff CB : American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry, 74:399–405, 2017.